*Optimal dilutions/concentrations should be determined by the researcher.
Not tested in other applications.
The antibody shows 20% cross-reactivity with recombinant human MPIF-1, 10% cross-reactivity with recombinant human MIP-1δ and 1% cross-reactivity with recombinant mouse MDC, human HCC-1, human I-309, mouse MIP-1α, viral MIP-I, mouse MIP-1β and mouse MIP-1γ.
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
Batch dependent (Please refer to the vial label for the specific concentration.)
recombinant human MDC expressed in E. coli.
Purified by affinity chromatography
For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
C-C motif chemokine ligand 22 , A-152E5.1 , ABCD-1 , DC/B-CK , MDC , SCYA22 , STCP-1
MDC is a member of the beta (CC) chemokine family and induces chemotaxis or calcium mobilization in dendritic cells, IL-2 activated cells and activated T lymphocytes. MDC, also named stimulated T cell chemotactic protein (STCP-1), was isolated from clones of monocyted-derived macrophages and binds to CC chemokine receptor 4 (CCR4). MDC shows less than 35% identity to other C-C chemokine family members. It is expressed in dendritic cells, macrophages and activated monocytes. Expression is also detected in the tissues of thymus, lymph node and appendix. NH2- terminally truncated forms of natural MDC were isolated from a CD8+ T cell clone and have been reported to inhibit HIV-1 infection.